Increased serum IL-2R levels in coeliac disease are related to CD4 but not CD8 antigens

Journal of Pediatric Gastroenterology and Nutrition

Volumn 15, Issue 4, 1992, Pages 413-417

  Blanco, A ^a   Garrote, J A ^a   Arranz, E ^b   Alonso, M ^a   Clavo, C ^a  

^a UNIVERSITY OF VALLADOLID   (Spain)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Anti endomysial antibodies; Anti gliadin antibodies; CD4; CD8; Coeliac disease; Cytokines; IL 2 receptor

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GLIADIN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN A2; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR;

ADOLESCENT; ARTICLE; CELIAC DISEASE; CHILD; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REMISSION;

ADOLESCENT; ANTIGENS, CD4; ANTIGENS, CD8; CELIAC DISEASE; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLIADIN; HUMAN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INFANT; MALE; MUSCLE, SMOOTH; RECEPTORS, INTERLEUKIN-2; SUPPORT, NON-U.S. GOV'T;

EID: 0026776043     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/00005176-199211000-00008     Document Type: Article

References (24)

1. Ferguson A, Macdonald TT, MacClure JP, Holden RJ, Cell-mediated immunity to gliadin within the small-intestinal mu-cosa in coeliac disease. Lancet 1975;1:895-7.
2. Auricchio S, Buffolano W, Ciccimara F, de Vicenzi M, Si-lano V, Zapponi G, In vitro proliferation of lymphocytes from coeliac children and their first-degree relatives in response to wheat gliadin-derived peptides. J Pediatr Gastroenterol Nutr 1982;1:515-24.
3. Blanco A, Alonso ML, Cilleruelo ML, Soils P, Calvo C, Sánchez Villares E, Increased serum beta-2 microglobulin levels in active celiac disease. J Pediatr Gastr Nutr 1985;4: 388-92.
4. Descos L, Andre C, Beorchia S, Vincent C, Revillard JP, Serum levels of beta-2 microglobulin. A new marker of ac-tivity in Crohn’s disease. N Engl J Med 1979;301:440-1.
5. Rubin LA, Kuman CC, Fritz ME, et al. Soluble interleukin-2 receptors are released from activated human lymphoid cells in vitro. J Immunol 1985;135:3172-7.
6. Pui CH, Ip SH, Carrabis S, et al. Serum levels of CD8 an-tigen in childhood lymphoid malignancies: a possible indica tor of increased suppressor cell activity in poor risk patients. Blood 1988;72:1015-21.
7. Tomkinson BE, Brown MC, Ip SH, Carrabis S, Sullivan JL, Soluble CD8 during T cell activation. J Immunol 1989;142: 2230-6.
8. Mueller CH, Knoflach P, Zielinski CC, T-cell activation in Crohn’s disease. Increased levels of soluble interleukin-2 receptor in serum and in supematants of stimulated peripheral blood mononuclear cells. Gastroenterology 1990;98:639-46.
9. Crabtree JE, Heatley RV, Juby LD, Howdle PD, Losowsky MS, Serum interleukin-2 receptor in coeliac disease: response to treatment and gluten challenge. Clin Exp Immunol 1989;77:345-8.
10. Meuwisse GW, Diagnostic criteria in coeliac disease. Acta Paediatr Scand 1970;59:461-4.
11. Marsh MN, Studies of intestinal lymphoid tissue. III. Quantitative analysis of epithelial lymphocytes in the small intestine of human control subjects and of patients with coeliac disease. Gastroenterology 1980;79:481-92.
12. Leigh RJ, Marsh MN, Crowe P, Kelly C, Garner V, Gordon D. Studies of intestinal lymphoid infiltration of coeliac epithelium. Scand J Gastroenterol 1985;20:715-9.
13. Kelly J, O’Farrely C, O’Mahony C, Weir DG, Feighery C, Immunoperoxidase demonstration of the cellular composition of the normal and coeliac small bowel. Clin Exp Immunol 1987;681:77-82.
14. Malizia G, Trejdosiewicz LK, Wood GM, Howdle PD, Janossy G, Losowky MS, The microenvironment of coeliac disease: T cell phenotypes and expression of the T2 “T blast” antigen by small bowel lymphocytes. Clin Exp Immunol 1985;60:437-46.
15. Symons JA, Wood NC, Di Giovine FS, Duff GW, Soluble IL-2 receptor in rheumatoid arthritis: correlation with disease activity, IL-1 and IL-2 inhibition. J Immunol 1988;141: 2612-8.
16. Scollard DM, Wagner DK, Nelson DL, Release of soluble interleukin-2 receptor (Tac peptide) in vivo during human immune responses to tuberculin. Clin Immunol Immunopa-thol 1988;46:450-5.
17. Selby WS, Janossy G, Bofill M, Jewell DP, T lymphocyte subsets in human intestinal mucosa: the findings in normal mucosa and in the mucosa of patients with coeliac disease. Clin Exp Immunol 1983;52:219-28.
18. Fujimoto J, Levy S, Levy R, Spontaneous release of the Leu-2 (T8) molecule from human T cells. J Exp Med 1983; 59:752-66.
19. Doyle C, Strominger J, Interaction between CD4 and class II MHC molecules mediates cell adhesion. Nature 1987;330: 256-8.
20. Keller RJ, Jackson RA, Developmental regulation of serum interleukin-2 receptor concentrations: attenuation of the childhood peak in patients at risk for developing or having recently developed type I diabetes mellitus. J Pediatr 1989; 114:816-9.
21. Freedman AR, Hooper LB, Ciclitira PJ, Studies of isolated small intestine lymphocytes (SIL) from coeliac patients and controls [Abstract], International Coeliac Symposium, London, 1988;12.
22. Garrote JA, Blanco A, Alonso M, Arranz E, Calvo C, Use-fulness of antiendomysial antibodies as a serological marker in coeliac children. Pediatr Allergy Immunol 1991;4:199-208.
23. Garrote JA, Blanco A, Alonso M, Calvo C, Izquierdo B, Anti-endomysial antibodies predict the intestinal villous atrophy in coeliac children. Study of IgA subclass. Clin Exp Allergy 1990;(suppl 1):52.
24. Karpati S, Burgin-Wolf A, Krieg T, Meurer M, Stolz W, Braun-Falco O, Binding to human jejunum of serum IgA antibody from children with coeliac disease. Lancet 1990; 336:1335-8.